Hsiang-Chun Chen

817 total citations · 1 hit paper
34 papers, 554 citations indexed

About

Hsiang-Chun Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Hsiang-Chun Chen has authored 34 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Hsiang-Chun Chen's work include Prostate Cancer Treatment and Research (16 papers), PARP inhibition in cancer therapy (13 papers) and Cancer Genomics and Diagnostics (5 papers). Hsiang-Chun Chen is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), PARP inhibition in cancer therapy (13 papers) and Cancer Genomics and Diagnostics (5 papers). Hsiang-Chun Chen collaborates with scholars based in United States, United Kingdom and France. Hsiang-Chun Chen's co-authors include Karim Fizazi, Fred Saad, Johann S. de Bono, Cynthia G. Healy, Celestia S. Higano, Akos Czibere, Niven Mehra, Consuelo Buttigliero, Marielena Mata and Xuemei Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Hsiang-Chun Chen

30 papers receiving 549 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial

2021 183 citations Johann S. de Bono, Niven Mehra et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Hsiang-Chun Chen

Since Specialization

Citations

This map shows the geographic impact of Hsiang-Chun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiang-Chun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiang-Chun Chen more than expected).

Fields of papers citing papers by Hsiang-Chun Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiang-Chun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiang-Chun Chen. The network helps show where Hsiang-Chun Chen may publish in the future.

Co-authorship network of co-authors of Hsiang-Chun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiang-Chun Chen. A scholar is included among the top collaborators of Hsiang-Chun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiang-Chun Chen. Hsiang-Chun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations—Genomic Features Associated with Response to Therapy 2025 ·European Urology Oncology ·(unknown), Johann S. de Bono, Alexander Laird, Philippe Barthélémy, R. Delva, Tanya B. Dorff, Marco Maruzzo, (unknown), Jean‐Pascal Machiels, Herlinde Dumez, Vincent Renard, Julia F. Hopkins, Lee A. Albacker, Hsiang-Chun Chen, Cynthia G. Healy, (unknown), Jijumon Chelliserry, Inge M. van Oort, Giorgio V. Scagliotti, Niven Mehra	0
2	TALAPRO-3 Clinical Trial Protocol: Phase III Study of Talazoparib Plus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer 2023 ·Future Oncology ·Neeraj Agarwal, Fred Saad, Arun Azad, Joaquı́n Mateo, Nobuaki Matsubara, Neal D. Shore, Jayeta Chakrabarti, Hsiang-Chun Chen, Silvana Lanzalone, (unknown), Karim Fizazi	19
3	Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses 2022 ·The Oncologist ·Niven Mehra, Karim Fizazi, Johann S. de Bono, Philippe Barthélémy, Tanya B. Dorff, (unknown), Jean‐Pascal Machiels, Davide Bimbatti, Deepak Kilari, Herlinde Dumez, Consuelo Buttigliero, Inge M. van Oort, Elena Castro, Hsiang-Chun Chen, Nicola Di Santo, (unknown), Cynthia G. Healy, Giorgio V. Scagliotti	11
4	Evaluation of children’s cognitive load in processing and storage of their spatial working memory 2022 ·Frontiers in Psychology ·Hsiang-Chun Chen, (unknown), Tzu‐Hua Wang, Yen‐Ting Lai	1
5	Talapro-3: A phase 3, double-blind, randomized study of enzalutamide (ENZA) plus talazoparib (TALA) versus placebo plus enza in patients with DDR gene mutated metastatic castration-sensitive prostate cancer (mCSPC). 2022 ·Journal of Clinical Oncology ·Neeraj Agarwal, Arun Azad, Karim Fizazi, Joaquı́n Mateo, Nobuaki Matsubara, Neal D. Shore, Jayeta Chakrabarti, Hsiang-Chun Chen, Silvana Lanzalone, (unknown), Fred Saad, (unknown)	20
6	Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial breakdown → 2021 ·The Lancet Oncology ·Johann S. de Bono, Niven Mehra, Giorgio V. Scagliotti, Elena Castro, Tanya B. Dorff, (unknown), Arnulf Stenzl, Mark T. Fleming, Celestia S. Higano, Fred Saad, Consuelo Buttigliero, Inge M. van Oort, Alexander Laird, Marielena Mata, Hsiang-Chun Chen, Cynthia G. Healy, Akos Czibere, Karim Fizazi	183
7	Sensing with Contexts: Crying Reason Classification for Infant Care Center with Environmental Fusion 2020 ·Asia-Pacific Signal and Information Processing Association Annual Summit and Conference ·(unknown), (unknown), Hsiang-Chun Chen, Chi-Chun Lee	1
8	TALAPRO-1: A phase II study of talazoparib (TALA) in men with DNA damage repair mutations (DDRmut) and metastatic castration-resistant prostate cancer (mCRPC)—First interim analysis (IA). 2020 ·Journal of Clinical Oncology ·Johann S. de Bono, Niven Mehra, Celestia S. Higano, Fred Saad, Consuelo Buttigliero, Marielena Mata, Hsiang-Chun Chen, Cynthia G. Healy, M. Luisa Paccagnella, Akos Czibere, Karim Fizazi	34
9	FADS Genetic Variants in Taiwanese Modify Association of DHA Intake and Its Proportions in Human Milk 2020 ·Nutrients ·Wen‐Chieh Wu, Hung‐Chih Lin, Wen‐Ling Liao, (unknown), An‐Chyi Chen, Hsiang-Chun Chen, Hsiang‐Yu Lin, Lina Liao, Pei‐Min Chao	8
10	Eye movement indices of memory reveal re-processing of visual information: Evidence from Chinese characters 2018 ·Visual Cognition ·Yuh‐Shiow Lee, Hsiang-Chun Chen	0
11	Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models 2017 ·Blood ·Natalia Baran, (unknown), Shannon Sweeney, Alessia Lodi, Shelley M. Herbrich, Antonio Cavazos, Helen Ma, Ningping Feng, Hsiang-Chun Chen, Marcin M. Kamiński, Kenneth Dunner, Guilin Tang, Gheath Alatrash, Jennifer R. Molina, Mónica L. Guzmán, Jing Ning, Stefano Tiziani, Joseph R. Marszalek, Marina Konopleva	1
12	Lymph node metastasis in gastric cancer: Location of positive station to predict survival after preoperative therapy. 2017 ·Journal of Clinical Oncology ·Naruhiko Ikoma, Jeannelyn S. Estrella, Mariela A. Blum Murphy, Hsiang-Chun Chen, Xuemei Wang, Keith F. Fournier, Paul F. Mansfield, Jaffer A. Ajani, Brian D. Badgwell	1
13	Parental Perceptions of Early Childhood English Education 2016 ·International Journal on Studies in English Language and Literature ·Ching‐Ying Lin, Hsiang-Chun Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	5
14	Parental Perceptions of Early Childhood English Education 2016 ·International Journal on Studies in English Language and Literature ·Ching‐Ying Lin, Hsiang-Chun Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
15	Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers 2015 ·Clinical Cancer Research ·Ana M. Aparicio, Li Shen, Elsa Li Ning Tapia, Jing‐Fang Lu, Hsiang-Chun Chen, Jiexin Zhang, Guanglin Wu, Xuemei Wang, Patricia Troncoso, Paul G. Corn, Timothy C. Thompson, Bradley M. Broom, Keith Baggerly, Sankar N. Maity, Christopher J. Logothetis	192
16	The eye movement measure of memory and its relationship with explicit measures 2015 ·Consciousness and Cognition ·Hsiang-Chun Chen, Yuh‐Shiow Lee	4
17	Approximate uniform shrinkage prior for a multivariate generalized linear mixed model 2015 ·Journal of Multivariate Analysis ·Hsiang-Chun Chen, Thomas E. Wehrly	4
18	Molecular characterization of clinically defined aggressive variant prostate cancer (AVPCa) in prospectively collected tissues and corresponding patient derived xenografts (PDX). 2015 ·Journal of Clinical Oncology ·Ana M. Aparicio, Li Shen, Elsa Li Ning Tapia, Jing‐Fang Lu, Hsiang-Chun Chen, Jiexin Zhang, Guanglin Wu, Xuemei Wang, Patricia Troncoso, Paul G. Corn, Timothy C. Thompson, Bradley M. Broom, Keith Baggerly, Christopher J. Logothetis, Sankar N. Maity	1
19	Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in First Remission Improves Outcome Irrespective of FLT3-ITD Allelic Burden Among Patients with Acute Myeloid Leukemia and FLT3-ITD Mutation 2014 ·Blood ·Betül Oran, Richard E. Champlin, Jörge E. Cortes, Marcos de Lima, Xuemei Wang, Hsiang-Chun Chen, Farhad Ravandi, Stefan O. Ciurea, Hagop M. Kantarjian, Gautam Borthakur	0
20	A phase II study of preoperative chemotherapy and chemoradiation for localized gastric and gastroesophageal junction adenocarcinoma (LGCA). 2014 ·Journal of Clinical Oncology ·Elena Elimova, Roopma Wadhwa, Kazuki Sudo, Hironori Shiozaki, Rebecca Slack, Hsiang-Chun Chen, Brian D. Badgwell, Aurelio Matamoros, Jeffrey H. Lee, Brian Weston, Manoop S. Bhutani, Mariela A. Blum, Jeannelyn S. Estrella, Prajnan Das, Jaffer A. Ajani	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact